Transparency and accountability in the negotiation of the US-Mexico-Canada trade agreement: the case of pharmaceuticals
Background: Transparency and accountability are essential components at all stages of the trade negotiation process. This study reports on the findings of an evaluation of the United States' public consultation process during the re-negotiation of the North American Free Trade Agreement (NAFTA)...
Gardado en:
Main Authors: | Anna S Y Wong, BSc (Author), Clarke B Cole, MSc (Author), Jillian C Kohler, PhD (Author) |
---|---|
Formato: | Libro |
Publicado: |
Elsevier,
2021-03-01T00:00:00Z.
|
Subjects: | |
Acceso en liña: | Connect to this object online. |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares
-
Intellectual property and access to medicines: mapping public attitudes toward pharmaceuticals during the United States-Mexico-Canada Agreement (USMCA) negotiation process
por: Anna S. Y. Wong, et al.
Publicado: (2021) -
An evaluation of transparency and accountability in Brazil's pharmaceutical sector
por: M.G. Martinez, et al.
Publicado: (2016) -
Can a multistakeholder initiative improve transparency and accountability in the pharmaceutical sector? Evidence from the Medicines Transparency Alliance
por: Taryn Vian, PhD, et al.
Publicado: (2017) -
The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk
por: Jillian Clare Kohler, et al.
Publicado: (2020) -
Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts
por: Deborah Gleeson, et al.
Publicado: (2019)